Clinical Trials Logo

Clinical Trial Summary

The objective of this study was to evaluate intubating condition using the McGrath® VL Series 5, with and without muscle relaxant


Clinical Trial Description

Thirty-four patients with ASA classification I-II, who required oroendotracheal tube intubation, were studied in this prospective, double-blinded, randomized, clinical trial. Anesthesia was induced using fentanyl 1.5 mcg/kg, xylocaine 1.5 mg/kg and propofol 3 mg/kg. Patients were randomly assigned to one of the two groups to receive either rocuronium 0.6 mg/kg or saline intravenously. The Mcgrath® VL intubation was initiated after 90s, when the patients were fully relaxed. The primary outcome was to compare tracheal intubating conditions between two groups. The secondary outcomes were the success rate in the first attempt intubation, time to intubation, the required propofol dose for intubation and anesthetic complications. Statistical analyses were performed using the R program version 2.14.2. The level of statistical significance was set at p < 0.05. ;


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02575716
Study type Interventional
Source Prince of Songkla University
Contact
Status Completed
Phase Phase 1
Start date March 2013
Completion date March 2014

See also
  Status Clinical Trial Phase
Completed NCT03058263 - Effect of Neostigmine on the Recovery of Rocuronium: A Comparison Between Partial and TOF Ratio-Based Dose Phase 1/Phase 2
Recruiting NCT04344262 - Small Doses Muscle Relaxant in General Anesthesia N/A